MRNA - Moderna, Inc.
57.8
7.970 13.789%
Share volume: 22,334,586
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$49.83
7.97
0.16%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-07-2024 | 02-21-2025 | 05-01-2025 | 08-01-2025 | 11-06-2025 | 02-20-2026 | |
| Assets | |||||||||
| Total Assets | 16.729 B | 15.680 B | 15.803 B | 14.142 B | 12.704 B | 12.010 B | 12.135 B | 12.338 B | |
| Current Assets | 9.600 B | 9.661 B | 9.666 B | 8.099 B | 6.766 B | 6.171 B | 6.598 B | 6.544 B | |
| Inventories | 295.000 M | 399.000 M | 412.000 M | 117.000 M | 128.000 M | 240.000 M | 332.000 M | 153.000 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 6.472 B | 6.010 B | 5.223 B | 5.098 B | 4.352 B | 3.852 B | 3.372 B | 3.204 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.051 B | 2.478 B | 1.644 B | 1.927 B | 1.623 B | 1.279 B | 1.132 B | 2.595 B | |
| Total Non-current Assets | 3.638 B | 2.326 B | 2.335 B | 2.494 B | 2.418 B | 2.374 B | 2.143 B | 2.336 B | |
| Property Plant Equipment | 2.063 B | 2.196 B | 2.381 B | 2.196 B | 2.212 B | 2.169 B | 2.126 B | 2.134 B | |
| Other Assets | 5.066 B | 3.823 B | 3.756 B | 3.847 B | 3.726 B | 3.670 B | 3.411 B | 3.660 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 16.729 B | 15.680 B | 15.803 B | 14.142 B | 12.704 B | 12.010 B | 12.135 B | 12.338 B | |
| Total liabilities | 3.912 B | 3.968 B | 3.876 B | 3.241 B | 2.638 B | 2.611 B | 2.805 B | 3.688 B | |
| Total current liabilities | 2.380 B | 2.363 B | 2.201 B | 2.206 B | 1.604 B | 1.572 B | 1.681 B | 1.987 B | |
| Accounts Payable | 183.000 M | 279.000 M | 373.000 M | 405.000 M | 226.000 M | 175.000 M | 267.000 M | 317.000 M | |
| Other liabilities | 899.000 M | 1.510 B | 955.000 M | 977.000 M | 941.000 M | 974.000 M | 941.000 M | 958.000 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 590.000 M | |
| Other liabilities | 899.000 M | 1.510 B | 955.000 M | 977.000 M | 941.000 M | 974.000 M | 941.000 M | 958.000 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 12.817 B | 11.712 B | 11.927 B | 10.901 B | 10.066 B | 9.399 B | 9.330 B | 8.650 B | |
| Common stock | 487.000 M | 631.000 M | 751.000 M | 866.000 M | 982.000 M | 1.127 B | 1.254 B | 1.382 B | |
| Retained earnings | 12.431 B | 11.152 B | 11.165 B | 10.045 B | 9.074 B | 8.249 B | 8.049 B | 7.223 B |